Aripiprazole in the treatment of acute episode of schizophrenia: a real-world study in China

Author:

Li Qian1,Su Yun’ai1,Liao Xuemei1,Fang Maosheng2,Gao Jianliang3,Xu Jia4,Duan Mingjun5,Yu Haiying6,Yang Yang7,Chen Zhiyu8,Liu Jintong9,Yan Shaoxiao10,Yao Peifen11,Li Shuying12,Wang Changhong13,Wu Bin14,Zhang Congpei4,Si Tianmei1

Affiliation:

1. Department of Psychopharmacology, Peking University Sixth Hospital (Institute of Mental Health), NHC Key Laboratory of Mental Health (Peking University), National Clinical Research Center for Mental Disorders (Peking University Sixth Hospital), Beijing 100191, China

2. Department of Psychiatry, Wuhan Mental Health Center, Wuhan, Hubei 430012, China

3. Department of Child and Adolescent Psychology, the Fourth People's Hospital of Hefei, Hefei, Anhui 230022, China

4. Mental Health Center, the First Psychiatric Hospital of Harbin, Harbin, Heilongjiang 150056, China

5. Department of Science and Education, the Fourth People's Hospital of Chengdu, Chengdu, Sichuan 610036, China

6. Department of Psychiatry, the Chinese People's Liberation Army 904th Hospital, Changzhou, Jiangsu 213003, China

7. Department of Psychiatry, Beijing Anding Hospital, Beijing 100029, China

8. Department of Psychiatry, Hangzhou Seventh People's Hospital, Hangzhou, Zhejiang 310063, China

9. Department of Adolescent and Child Psychological Behavior, Shandong Mental Health Center, Jinan, Shandong 250014, China

10. Department of Integrated Chinese and Western Medicine, Beijing Huilongguan Hospital, Beijing 102208, China

11. Department of Psychiatry, Shanghai Mental Health Center, Shanghai 201109, China

12. Department of Psychiatry, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, China

13. Department of Psychiatry, the Second Affiliated Hospital of Xinxiang Medical University, Xinxiang, Henan 456750, China

14. Department of Psychiatry, Xi’an Mental Health Center, Xi’an, Shaanxi 710067, China.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine,General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3